Abstract |
The in vivo activity of ceftriaxone was examined in an experimentally induced subcutaneous infection involving Bacteroides fragilis and Escherichia coli. Mice were challenged with 1 of 10 strains of B. fragilis or E. coli, or a dual combination of the two species. The efficacy was measured by a reduction in the count of viable organisms when antimicrobial treatment was initiated 1 h after challenge and continued for 5 days. Ceftriaxone exhibited impressive activity against E. coli but showed poor in vivo activity versus B. fragilis. The antimicrobial activity of ceftriaxone was influenced by the microbial interaction in our dual-isolate model. Pharmacokinetic studies showed that ceftriaxone penetrated into abscesses and achieved peak levels of about 40% of the peak serum levels. However, in abscesses infected with B. fragilis nearly all biological activity of ceftriaxone was lost.
|
Authors | M Dezfulian, R A Bitar, J G Bartlett |
Journal | Chemotherapy
(Chemotherapy)
1993 Sep-Oct
Vol. 39
Issue 5
Pg. 355-60
ISSN: 0009-3157 [Print] Switzerland |
PMID | 8370326
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Bacteroides Infections
(microbiology)
- Bacteroides fragilis
(drug effects)
- Ceftriaxone
(blood, therapeutic use)
- Escherichia coli
(drug effects)
- Escherichia coli Infections
(microbiology)
- Mice
- Microbial Sensitivity Tests
- Skin Diseases, Bacterial
(microbiology)
|